Vaccitech - Stock Price History | VACC

Historical daily share price chart and data for Vaccitech since 2021 adjusted for splits. The latest closing stock price for Vaccitech as of September 27, 2021 is 15.62.
  • The all-time high Vaccitech stock closing price was 17.00 on May 17, 2021.
  • The Vaccitech 52-week high stock price is 17.99, which is 15.2% above the current share price.
  • The Vaccitech 52-week low stock price is 12.25, which is 21.6% below the current share price.
  • The average Vaccitech stock price for the last 52 weeks is 15.01.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Vaccitech Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.533B $0.005B
Vaccitech plc is a clinical-stage biopharmaceutical company. It engaged in the discovery and development of novel immunotherapeutics and vaccines for the treatment and prevention of infectious diseases and cancer. Vaccitech plc is based in OXFORD, United Kingdom.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $133.838B 8.91
Bio-Rad Laboratories (BIO.B) United States $23.483B 50.05
QIAGEN (QGEN) Netherlands $12.341B 20.90
Biohaven Pharmaceutical Holding (BHVN) United States $8.723B 0.00
Emergent Biosolutions (EBS) United States $2.813B 6.79
Arcus Biosciences (RCUS) United States $2.568B 0.00
Myovant Sciences (MYOV) United Kingdom $2.170B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.949B 0.00
Zymeworks (ZYME) Canada $1.323B 0.00
Ambrx Biopharma (AMAM) United States $0.509B 0.00
SQZ Biotechnologies (SQZ) United States $0.428B 0.00
Enzo Biochem (ENZ) United States $0.174B 51.29